Cns Pharmaceuticals Inc

Research Cns Pharmaceuticals Inc (CNSP) on Bullrun: market cap USD 6.06M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCNSP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 6.06M
• Financial periodFY2025
• Net income-USD 15.85M
• Free cash flow-USD 13.83M

Valuation Snapshot

latest market cap is USD 6.06M.

About Cns Pharmaceuticals Inc

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma;

Frequently asked questions

What is Cns Pharmaceuticals Inc's market cap?

Cns Pharmaceuticals Inc's market capitalization is USD 6.06M.

What does Cns Pharmaceuticals Inc do?

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States.